Endovascular Treatment Effective with Carotid Disease
|
By HospiMedica International staff writers Posted on 12 Jun 2017 |
|
Image: Research shows clearing blood clots in stroke patients is effective even those with blocked carotid arteries (Photo courtesy of FotoSearch).
Intra-arterial treatment (IAT) for acute ischemic stroke caused by intracranial proximal occlusion is effective even in patients with extracranial carotid disease (ECD), according to a new study.
Researchers at Academic Medical Center (AMC; Amsterdam, The Netherlands), Leiden University Medical Center (LUMC, The Netherlands), and other institutions conducted a subgroup analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment (MR CLEAN) study to examine if the presence of ECD--defined as cervical internal carotid artery stenosis higher than 50%, or occlusion--modified the effect of IAT for intracranial proximal anterior circulation occlusion. The MR CLEAN IAT protocol included intra-arterial thrombolysis, mechanical treatment, or both as treatment for acute ischemic stroke.
The primary measure was functional outcome, as measured by modified Rankin Scale at 90 days and reported as adjusted common odds ratio (acOR) for a shift in direction of a better outcome. The results showed that functional outcome was associated with an acOR of 1.67 in favor of the IAT intervention. In the analysis of the pre-specified subgroup of patients with ECD, acOR was 3.1, compared to an acOR of 1.3 in patients presenting without ECD. The study was published on May 23, 2017, in Annals of Internal Medicine.
“The presence of ECD is associated with less favorable clinical outcomes in patients with acute ischemic stroke caused by intracranial proximal occlusion, and acute IAT in the setting of extracranial and intracranial lesions is considered challenging,” concluded lead author Olvert Berkhemer, MD, PhD, of AMC, and colleagues. “IAT may be at least as effective in patients with ECD as in those without ECD, and it should not be withheld in these complex patients with acute ischemic stroke.”
Based on the Framingham Heart Study and Cardiovascular Health Study populations, the prevalence of ECD is approximately 9% in men and 6–7% in women, and it accounts for up to 15–20% of all ischemic strokes. Several possible mechanisms are involved, including atheroembolism of cholesterol crystals or other debris, artery-to-artery embolism of thrombus, dissection, acute thrombotic occlusion, and reduced cerebral perfusion with plaque growth.
Related Links:
Academic Medical Center
Leiden University Medical Center
Researchers at Academic Medical Center (AMC; Amsterdam, The Netherlands), Leiden University Medical Center (LUMC, The Netherlands), and other institutions conducted a subgroup analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment (MR CLEAN) study to examine if the presence of ECD--defined as cervical internal carotid artery stenosis higher than 50%, or occlusion--modified the effect of IAT for intracranial proximal anterior circulation occlusion. The MR CLEAN IAT protocol included intra-arterial thrombolysis, mechanical treatment, or both as treatment for acute ischemic stroke.
The primary measure was functional outcome, as measured by modified Rankin Scale at 90 days and reported as adjusted common odds ratio (acOR) for a shift in direction of a better outcome. The results showed that functional outcome was associated with an acOR of 1.67 in favor of the IAT intervention. In the analysis of the pre-specified subgroup of patients with ECD, acOR was 3.1, compared to an acOR of 1.3 in patients presenting without ECD. The study was published on May 23, 2017, in Annals of Internal Medicine.
“The presence of ECD is associated with less favorable clinical outcomes in patients with acute ischemic stroke caused by intracranial proximal occlusion, and acute IAT in the setting of extracranial and intracranial lesions is considered challenging,” concluded lead author Olvert Berkhemer, MD, PhD, of AMC, and colleagues. “IAT may be at least as effective in patients with ECD as in those without ECD, and it should not be withheld in these complex patients with acute ischemic stroke.”
Based on the Framingham Heart Study and Cardiovascular Health Study populations, the prevalence of ECD is approximately 9% in men and 6–7% in women, and it accounts for up to 15–20% of all ischemic strokes. Several possible mechanisms are involved, including atheroembolism of cholesterol crystals or other debris, artery-to-artery embolism of thrombus, dissection, acute thrombotic occlusion, and reduced cerebral perfusion with plaque growth.
Related Links:
Academic Medical Center
Leiden University Medical Center
Gold Member
12-Channel ECG
CM1200B
Rapid Sepsis Test
SeptiCyte RAPID
Gas Analyzer
GE SAM
Latest Surgical Techniques News
- Fluorescence Imaging Reveals Nerves Under Normal Operating-Room Lighting
- Programmable Microwave Ablation System Gains CE Mark for Minimally Invasive Tissue Ablation
- Researchers Develop Microbots to Help Drugs Reach Blood Clots
- Minimally Invasive Balloon Procedure May Redirect Blood Flow During Cardiac Arrest
- First Stemless Reverse Shoulder Arthroplasty System Receives FDA Clearance in U.S.
- First U.S. Procedures Successfully Completed With New GERD Implant
- Study Explores 4DCT Ventilation for Preoperative Assessment in Early Lung Cancer
- Dual-Technique Approach Improves Stent Expansion in Calcified Coronary Lesions
- FDA Approves First Transcatheter Device for Paravalvular Leak Closure
- Smaller Surgical Margins May Help Protect Healthy Tissue in Young Sarcoma Patients
- BD Launches TIPS Stent Graft for Personalized Portal Hypertension Treatment
- Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma
- FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots
- Miniature Image Sensor Enables Digital Imaging in Single-Use Endoscopes
- Transcatheter Repair System Gains FDA Approval for Severe Tricuspid Regurgitation
- Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia
Channels
Artificial Intelligence
view channel
AI Analysis of Smartwatch ECGs May Help Detect Weakened Heart Function
Left ventricular systolic dysfunction (LVSD) occurs when the heart’s main pumping chamber does not contract effectively. The condition can remain asymptomatic for some time but may progress to symptomatic... Read more
AI Tool Speeds Echocardiogram Reporting With Comparable Accuracy
Echocardiography is the most widely used form of cardiac imaging, playing a key role in diagnosing heart disease and guiding treatment decisions. However, reviewing ultrasound images and documenting cardiac... Read more
Critical Care
view channel
Inhaled Therapy Uses Modified Bacteria to Break Down Pseudomonas Biofilms
Biofilms are protective layers of bacteria that can form inside endotracheal tubes during mechanical ventilation, making infections difficult to treat because intravenous antibiotics often struggle to... Read more
Miniature Wearable Sensor Enables Continuous Cuffless Blood Pressure Monitoring
Blood pressure is a key indicator of cardiovascular health, but conventional cuff-based measurement typically provides only a single reading at one point in time. This can limit monitoring during everyday... Read more
Patient Care
view channel
Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery
Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more
Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more
Medical Imaging
view channel
Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis
Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more
MRI Test Identifies Candidates for Lower-Dose Radiotherapy in HPV Throat Cancer
Human papillomavirus (HPV)-positive oropharyngeal cancer is a throat cancer linked to HPV infection. Its incidence is rising, and many patients receive high-dose radiotherapy that can cause long-term swallowing... Read more
Health IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Point of Care
view channel
New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Business
view channel
Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings
Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
